Abstract
Diabetes mellitus causes a variety of changes in the vascular system, affecting both the micro-and macrovasculature. Classical pathologies in the microvasculature are manifested as diabetic retinopathy and nephropathy. Macrovascular diseases are observed in the coronary arteries, large peripheral vasculature involving mostly the lower limbs, and cerebral vessels. In addition, diabetes and insulin resistance are strongly associated with essential hypertension, and appear to accelerate the development of atherosclerosis (1,2). Vascular abnormalities of diabetes include nutrient delivery, defense against foreign agents, hemostasis/fibrinolysis, and repair of injury. Recent clinical and epidemiologic studies have shown that intensive insulin treatment with partial normalization of glycemic control delays the appearance and possibly slows the progression of diabetic microvascular complications and neuropathy in type I diabetic patients. However, the evidence that good glycemic control can prevent or slow the progression ofmacrovascular diseases is not clear (3). In this chapter, we discuss the cellular and molecular mechanisms that may explain the underlying pathological and clinical abnormalities observed in the vascular complications of diabetes.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Kannel WB, McGee DL. Diabetes and glucose tolerance as risk factors for cardiovascular disease: The Framingham Study. Diabetes Care 1979;2:120–126.
Krolewski AS, Warram JH, Rand LI, Kahn CR. Epidemiologic approach to etiology of type I diabetes mellitus and its complications. N Engl J Med 1987;317:1390–1398.
The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993;329:977–986.
Morgensen CE, Osterby R, Gundersen HJG. Early functional and morphologic vascular renal consequences of the diabetic state. Diabetologia 1979;17:71–76.
Williamson JR, Kilo C. Extracellular matrix changes in diabetes mellitus. In: Scarpelli DG, Migaki G, eds. Comparative Pathobiology of Major Age-Related Diseases. Liss, New York, 1984, pp. 269–278.
Danne T, Spiro MJ, Spiro RG. Effect of high glucose on type IV collagen production by cultured glomerular epithelial endothelial and mesangial cells. Diabetes 1993;42:170–177.
Mohan PS, Carter WG, Spiro RG. Occurrence of type VI collagen in extracellular matrix of renal glomeruli and its increase in diabetes. Diabetes 1990;39:31–37.
Wakisaka M, Spiro MJ, Spiro RG. Synthesis of type VI collagen by cultured glomerular cells and comparison of its regulation by glucose and other factors with that of type IV collagen. Diabetes 1994;43:95–103.
Shimomura H, Spiro RG. Studies on macromolecular components of human glomerular BM and alterations in diabetes. Diabetes 1987;36:374–381.
Garlick RL, Bunn HF, Spiro RG. Nonenzymatic glycation of basement membranes from human glomeruli and bovine sources. Effect of diabetes and age. Diabetes 1988;37:1144–1150.
Brownlee M, Lecture L. Glycation and diabetic complications. Diabetes 1994;43:836–841.
Brownlee M. Advanced protein glycosylation in diabetes and aging. Annu Rev Med 1995;46:223–234.
King GL, Shiba T, Oliver J, Inoguchi T, Bursell S-E. Cellular and molecular abnormalities in the vascular endothelium of diabetes mellitus. Annu Rev Med 1994;45:179–188.
King GL, Banskota NK. Mechanisms of diabetic microvascular complications. In: Kahn CR, Weir GC, eds. Joslin’s Diabetes Mellitus, 13th ed. Lea & Febiger, Philadelphia, PA, 1994, pp. 633–647.
Lorenzi M. Glucose toxicity in the vascular complications of diabetes: the cellular perspective. Diab Metab Rev 1992;8:85–103.
Merimee TJ. Diabetic retinopathy: a synthesis of perspectives. N Engl J Med 1990;322:978–983.
Cogan DG, Toussaint D, Kuwabara T. Retinal vascular patterns IV: diabetic retinopathy. Arch Ophthalmol 1961;60:100–112.
Kuwabara T, Cogan DG. Retinal vascular patterns VI: mural cells of the retinal capillaries. Arch Ophthalmol 1963;69:492a-502a.
Spiro RG. Biochemistry of the renal glomerular BM and its alterations in diabetes mellitus. N Engl J Med 1973:388:1337–1342.
Colwell JA, Lopes-Virella M, Halushka PV. Pathogenesis of atherosclerosis in diabetes mellitus. Diabetes Care 1981;4:121–133.
LoGerfo FW, Coffman JD. Current concepts: vascular and microvascular disease of the foot in diabetes. Implications for foot care. N Engl J Med 1984;311:1615–1619.
Greene D, Lattimer SA, Sima AAF. Sorbitol, phosphoinositides and sodium-potassium-ATPase in the pathogenesis of diabetic complications. N Engl J Med 1987;316:599–606.
Williamson JR, Chang K, Frangos M, Hasan KS, Ido Y, Kawamura T, Nyengaard JR, Van den Enden M, Kilo C, Tilton RG. Hyperglycemic pseudohypoxia and diabetic complications. Diabetes 1993;42:801–813.
Engerman RL, Kern TS. Aldose reductase inhibition fails to prevent retinopathy in diabetic and galactosemic dogs. Diabetes 1993;42:820–825.
Xia P, Inoguchi T, Kern TS, Engerman RL, Oates PJ, King GL. Characterization of the mechanism for the chronic activation of diacylglycerol-protein kinase C pathway in diabetes and hypergalactosemia. Diabetes 1994;43:1122–1129.
Xia P, Kramer RM, King GL. Identification of the mechanism for the inhibition of Na,K-adenosine triphosphatase by hyperglycemia involving activation of protein kinase C and cytosolic phospholipase A2. J Clin Invest 1995;96:733–740.
Vlassara H, Brownlee M, Manogue KR, Dinarello CA, Pasagian A. Role in normal tissue remodeling. Science 1988;240:1546–1548.
Hammes HP, Martin S, Federlin K, Geisen K, Brounlee M. Aminoguanidine treatment inhibits the development of experimental diabetic retinopathy. Proc Natl Acad Sci USA 1991;88:11555–11558.
Baynes JW. Perspectives in diabetes. Role of oxidative stress in development of complications in diabetes. Diabetes 1991;40:405–412.
Ferrara N, King GL. Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. N Engl J Med 1994;331:1480–1487.
Merimee TJ. Diabetic retinopathy: a synthesis of perspectives. N Engl J Med 1990;322:978–983.
Sharma K, Ziyadeh FN. The emerging role of transforming growth factor-beta in kidney diseases. Am J Physiol 1994;266(6 Pt 2):F829—F842.
Grant M, King GL. IGF-1 and blood vessels: implications for microvascular and macrovascular disease. Diabetes Rev 1995;3:113–128.
Ferrannini E Hypertension as an insulin resistant disorder: role of obesity. In: Smith U, Bruun NE, Hedner T, Hokfelt B, eds. Novo Nordisk Foundation Symposium No. 5. Excerpta Medica, Amsterdam, 1991,123–135.
King GL, Davidheiser S, Banskota N, Oliver J, Inoguchi T. Insulin receptors and actions on vascular cells. In: Smith U, Bruun NE, Hedner T, Hokfelt B, eds. Novo Nordisk Foundation Symposium No. 5, Excerpta Medica, Amsterdam, 1991,183–187.
Kaiser N, Sasson S, Feener EP, Moller DE, King GL. Differential regulation of glucose transport and transporters by glucose in vascular endothelial and smooth muscle cells. Diabetes 1992;42:80–89.
Oliver FJ, de la Rubia G, Feener EP, Lee M-E, Loeken MR, Shiba T, Quertermous T, King GL. Stimulation of endothelin-1 gene expression by insulin in endothelial cells. J Biol Chem 1991;266: 23251–23256.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1996 Springer Science+Business Media New York
About this chapter
Cite this chapter
Hein, K.D., King, G.L. (1996). Vascular Abnormalities in Diabetes Mellitus. In: Sowers, J.R. (eds) Endocrinology of the Vasculature. Contemporary Endocrinology, vol 1. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-4612-0231-8_10
Download citation
DOI: https://doi.org/10.1007/978-1-4612-0231-8_10
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-4612-6672-3
Online ISBN: 978-1-4612-0231-8
eBook Packages: Springer Book Archive